Clinical outcome of radical cystectomy for patients with pT4 bladder cancer

International Journal of Urology

Volumn 15, Issue 1, 2008, Pages 58-61

  Furukawa, Junya ^a   Miyake, Hideaki ^a   Hara, Isao ^a   Takenaka, Atsushi ^a   Fujisawa, Masato ^a  

^a KOBE UNIVERSITY GRADUATE SCHOOL OF MEDICINE   (Japan)

Author keywords

Bladder cancer; Lymph node metastasis; pT4; Radical cystectomy

Indexed keywords

ADULT; AGED; ARTICLE; BLADDER CANCER; CANCER INVASION; CANCER RECURRENCE; CANCER SURGERY; CANCER SURVIVAL; CYSTECTOMY; FEMALE; HUMAN; LYMPH NODE METASTASIS; MAJOR CLINICAL STUDY; MALE; PREDICTOR VARIABLE; PRIORITY JOURNAL; RETROSPECTIVE STUDY; TREATMENT OUTCOME;

AGED; AGED, 80 AND OVER; CYSTECTOMY; FEMALE; FOLLOW-UP STUDIES; HUMANS; JAPAN; LYMPHATIC METASTASIS; MALE; MIDDLE AGED; MULTIVARIATE ANALYSIS; OUTCOME ASSESSMENT (HEALTH CARE); RETROSPECTIVE STUDIES; RISK FACTORS; SURVIVAL ANALYSIS; URINARY BLADDER NEOPLASMS;

EID: 37849041340     PISSN: 09198172     EISSN: 14422042     Source Type: Journal    
DOI: 10.1111/j.1442-2042.2007.01916.x     Document Type: Article

References (20)

1. Lerner SP, Skinner E, Skinner DG. Radical cystectomy in regionally advanced bladder cancer. Urol. Clin. N. Am. 1992 19 : 713 23.
2. Stein JP, Lieskovsky G, Cote R et al. Radical cystectomy in the treatment of invasive bladder cancer: long-term results in 1054 patients. J. Clin. Oncol. 2001 19 : 666 75.
3. Sweeney P, Millikan R, Donat M et al. Is there a therapeutic role for post-chemotherapy retroperitoneal lymph node dissection in metastatic transitional cell carcinoma of the bladder? J. Urol. 2003 169 : 2113 17.
4. Abdel-Latif M, Abol-Enein H, El-Baz M, Ghoneim MA. Nodal involvement in bladder cancer cases treated with radical cystectomy: incidence and prognosis. J. Urol. 2004 172 : 85 9.
5. Dalbagni G, Genega E, Hashibe M et al. Cystectomy for bladder cancer: a contemporary series. J. Urol. 2001 165 : 1111 16.
6. Madersbacher S, Hochreiter W, Burkhard F et al. Radical cystectomy for bladder cancer today - a homogeneous series without neoadjuvant therapy. J. Clin. Oncol. 2003 21 : 690 6.
7. Herr HW. Superiority of ratio based lymph node staging for bladder cancer. J. Urol. 2003 169 : 943 5.
8. Shen SS, Lerner SP, Muezzinoglu B, Truong LD, Amiel G, Wheeler TM. Prostatic involvement by transitional cell carcinoma in patients with bladder cancer and its prognostic significance. Hum. Pathol. 2006 37 : 726 34.
9. Esrig D, Freeman JA, Elmajian DA et al. Transitional cell carcinoma involving the prostate with a proposed staging classification for stromal invasion. J. Urol. 1996 156 : 1071 6.
10. Njinou Ngninkeu B, Lorge F, Moulin P, Jamart J, Van Cangh PJ. Transitional cell carcinoma involving the prostate: a clinicopathological retrospective study of 76 cases. J. Urol. 2003 169 : 149 52.
11. Cheville JC, Dundore PA, Bostwick DG et al. Transitional cell carcinoma of the prostate: clinicopathologic study of 50 cases. Cancer 1998 82 : 703 7.
12. Solsona E, Iborra I, Ricos JV, Monros JL, Casanova JL, Almenar S. The prostate involvement as prognostic factor in patients with superficial bladder tumors. J. Urol. 1995 154 : 1710 13.
13. Herr HW, Donat SM. Prostatic tumor relapse in patients with superficial bladder tumors: 15-year outcome. J. Urol. 1999 161 : 1854 7.
14. Japanese Urological Association. The Japanese Society of Pathology. General Rule for Clinical and Pathological Studies on Bladder Cancer. Kanehara, Tokyo, 2001.
15. Pollack A, Kagars GK, Cole CJ. The relationship of local control to distant metastases in muscle invasive bladder cancer. J. Urol. 1995 154 : 2059 64.
16. Ennis RD, Petrylak DP, Singh P et al. The effect of cystectomy, and perioperative methotrexate, vinblastine, doxorubicin and cisplatin chemotherapy on the risk and pattern of relapse in patients with muscle invasive bladder cancer. J. Urol. 2000 163 : 1413 18.
17. Bassi P, Ferrante GD, Piazza N et al. Prognostic factors of outcome after radical cystectomy for bladder cancer: a retrospective study of a homogeneous patient cohort. J. Urol. 1999 161 : 1491 7.
18. Harada K, Sakai I, Kurahashi T et al. Clinicopathological features of recurrence after radical cystectomy for patients with transitional cell carcinoma. Int. Urol. Nephrol. 2006 38 : 49 55.
19. Sengelov L, Kamby C, Schou G, von der Maase H. Prognostic factors and significance of chemotherapy in patients with recurrent metastatic transitional cell carcinoma of the bladder. Cancer 1994 74 : 123 33.
20. Konety BR, Joslyn SA. Factors influencing aggressive therapy for bladder cancer: an analysis of data from the SEER program. J. Urol. 2003 170 : 1765 71.